The DOI matches its Crossref record; 36 of the 39 references it cites were found in a registry or an index.
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis
Open accessAbstract
There is a growing interest in patient-reported outcomes (PROs) in rheumatology, which goes with a global trend for more ‘patient-centred care’. This review considers the use of PROs in trials, including their strengths and limitations. In rheumatoid arthritis (RA) trials, the most frequently used PROs to assess treatments include pain, patient global assessment, assessment of functional status, but also health-related quality of life and less commonly fatigue. Other aspects of importance for patients, such as sleep, psychological well-being or ability to cope, are rarely assessed. PROs as outcome measures in RA trials have strengths as well as limitations. PROs have face validity, they are reproducible and sensitive to change and they bring additional information beyond joint counts or acute phase reactants. However, their predictive validity for later outcomes has been little explored, some PROs show redundancy (they bring similar information) and, due to the apparently moderate link between some PROs such as fatigue and the disease process, the use of some PROs to inform treatment choices has been questioned. We suggest the choice of PROs for trials depends on the study objective and on the viewpoint of the stakeholder. There needs to be agreed prioritisation across all stakeholders about what is most important to collect in a trial, which is why a prioritisation and selection process is necessary. Trials in RA will continue to include PROs and their interpretation will become easier as our knowledge progresses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These have inherent limitations, however, in that they can be subjective and are prone to recall bias4,5.”
From Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis (2024) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Self-citationSmolen, J. S., Landewé, R., Breedveld, F. C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204573 · Cited by 1,763
Self-citationFelson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Chernoff, M., Fried, B., Furst, D., Goldsmith, C., Kieszak, S., Lightfoot, R., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360601 · Cited by 1,640
Felson, D. T., Smolen, J. S., Wells, G., Zhang, B., van Tuyl, L. H. D., Funovits, J., Aletaha, D., Allaart, C. F., Bathon, J., Bombardieri, S., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30129 · Cited by 1,022
Self-citationDeveloping core outcome measurement sets for clinical trials: OMERACT filter 2.0
Boers, M., Kirwan, J. R., Wells, G., Beaton, D., Gossec, L., d'Agostino, M.-A., Conaghan, P. G., Bingham, C. O., Brooks, P., Landewé, R., et al. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.11.013 · Cited by 781 · cited 1×
“The strong points of PROs PROs, like other outcome measures, need to be valid that is, need to have good psychometric properties.(26) This is largely the case as we will see (table 2).”
BackgroundSelf-citationFelson, D. T., Smolen, J. S., Wells, G., Zhang, B., van Tuyl, L. H. D., Funovits, J., Aletaha, D., Allaart, C. F., Bathon, J., Bombardieri, S., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.149765 · Cited by 777 · cited 2×
“As these criteria were developed based on predictive capacities for later joint destruction, it appears that patient global assessment may have an independent predictive capacity (on top of joint counts and acute phase reactants) to predict radiographic damage.(41) Overall, however, there is very limited knowledge of…”
BackgroundSelf-citationAnderson, J., Caplan, L., Yazdany, J., Robbins, M. L., Neogi, T., Michaud, K., Saag, K. G., O'dell, J. R., & Kazi, S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21649 · Cited by 748
Patients' perceptions of fatigue in rheumatoid arthritis: Overwhelming, uncontrollable, ignored
Hewlett, S., Cockshott, Z., Byron, M., Kitchen, K., Tipler, S., Pope, D., & Hehir, M. (2005) · Arthritis Care & Research · doi:10.1002/art.21450 · Cited by 434
Frosch, M., Strey, A., Vogl, T., Wulffraat, N. M., Kuis, W., Sunderkötter, C., Harms, E., Sorg, C., & Roth, J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<628::aid-anr20>3.0.co;2-x · Cited by 381
Kirwan, J., Minnock, P., Adebajo, A., Bresnihan, B., Choy, E., de Wit, M. P. T., Hazes, M. J. M. W., Richards, P., Saag, K. G., Suarez-Almazor, M. E., et al. (2007) · PubMed · Cited by 315
Research works printed but not linked: 1
- 10.1002/1529-0131(200003)43:3<506::aid-anr5>3.0.co;2-u · DOI
Cited by
2016 update of the EULAR recommendations for the management of early arthritis
Combe, B., Landewe, R., Daien, C. I., Hua, C., Aletaha, D., Álvaro-Gracia, J. M., Bakkers, M., Brodin, N., Burmester, G. R., Codreanu, C., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210602 · Cited by 609
“Finally, patient-reported outcomes such as quality of life, fatigue and physical function are key to evaluate outcome 71 72 and the committee has mandated them as part of disease monitoring.”
BackgroundSelf-citationNikiphorou, E., Radner, H., Chatzidionysiou, K., Desthieux, C., Zabalan, C., van Eijk-Hustings, Y., Dixon, W. G., Hyrich, K. L., Askling, J., & Gossec, L. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1151-6 · Cited by 270
Self-citationFautrel, B., Alten, R., Kirkham, B. W., de la Torre, I., Durand, F., Barry, J., Holzkaemper, T., Fakhouri, W., & Taylor, P. C. (2018) · Rheumatology International · doi:10.1007/s00296-018-4005-5 · Cited by 129
“In addition, the PROs used tend to reflect the requirements of the stakeholders [11].”
BackgroundKeystone, E. C., Taylor, P. C., Tanaka, Y., Gaich, C. L., DeLozier, A. M., Dudek, A., Zamora, J. V., Covarrubias-Cobos, J. A., Rooney, T. P., de Bono, S., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211259 · Cited by 128
Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
Choy, E., & Calabrese, L. H. (2017) · Rheumatology · doi:10.1093/rheumatology/kex391 · Cited by 129
Metadata
- Authors
- Gossec, L., Dougados, M., & Dixon, W.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Gossec, Laure
- Venue
- RMD Open
- Publisher
- BMJ
- Published
- 2015-04
- Volume
- 1
- Issue
- 1
- Pages
- e000019
- ISSN
- 2056-5933 (ISSN-L)
- PMC
- PMC4613162
- OpenAlex
- W2040963445
- Cited by
- 115
- References
- 39
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 8 · 2023: 6 · 2022: 12 · 2021: 14 · 2020: 15 · 2019: 15 · 2018: 11 · 2017: 14 · 2016: 7
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- RMD Open (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Medical Research Council (G0902272)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- patient-reported outcomes, rheumatoid arthritis, clinical trial endpoints, patient-centered care, health-related quality of life, fatigue, pain, patient global assessment, functional status, outcome measure selection, predictive validity, stakeholder prioritization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis. https://app.cochat.ai/papers/10.1136/rmdopen-2014-000019
- The paper
- Gossec, L., Dougados, M., & Dixon, W. (2015). Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis. RMD Open. https://doi.org/10.1136/rmdopen-2014-000019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
